News tagged ‘Leukemia’ clear
- A test developed by Dana-Farber scientists is the first to identify
which malignant blood cells are highly vulnerable to a promising type of
experimental drugs that unleash pent-up cell suicide factors to destroy
the cancer.
Tags: BasicResearch, Leukemia
- An analysis of two dozen clinical studies finds most adults with
poor-risk and intermediate-risk acute myeloid leukemia benefit from
allogeneic stem cell transplants.
Tags: BasicResearch, StemCellTransplant, Leukemia
- Researchers report that patients with high-risk acute AML who received a
cancer vaccine after a stem cell transplant had few complications and
mounted a strong immune system attack on the disease.
Tags: StemCellTransplant, Leukemia
- Scientists have found a way to switch off the behavior of a protein that drives uncontrolled cell growth in tumors.
Tags: Leukemia
- Results suggest kinase inhibitor, teamed with chemotherapy, might reduce
the need for donor stem cell transplantation in some AML patients.
Tags: KinaseInhibitor, Leukemia
Stand Up To Cancer announced the second round of awards for its Innovative Research Grants Program, naming the 13 young scientists who will receive a combined $9.74 million to conduct high-risk/high-reward translational cancer research. Dana-Farber's Catherine J. Wu, MD, is one of the recipients.
Tags: Grants, Honors, Prevention, Leukemia
When Charlie was diagnosed with acute lymphoblastic leukemia at age 4, his mother sent regular email updates to her large family and circle of friends. Her reflections grew into a touching chronicle of four years in the life of a child with cancer.
Tags: ChildhoodCancer, StemCellTransplant, PatientVideos, Leukemia
Tens of thousands of childhood cancer survivors are now in their 20s, 30s, and beyond, facing life-long risks of treatment-related health issues. Increasingly, primary care physicians will need to be knowledgeable about symptoms and complaints that might be related to cancer treatments their patients received decades ago.
Tags: ChildhoodCancer, Survivorship, Leukemia
Researchers have found several new altered genes that drive chronic lymphocitic leukemia through powerful DNA sequencing, a finding that could potentially help doctors predict whether a patient’s disease will progress rapidly or remain indolent for years.
Tags: BasicResearch, Leukemia
Researchers at Dana-Farber/Children's Hospital Cancer Center have created a peptide that overcomes drug resistance and reactivates programmed cell death in recurrent blood cancers.
Tags: chemotherapy, DrugResistance, Leukemia, Lymphoma